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Manipulation of serotonin (5HT) during early development has been shown to induce
long-lasting morphological changes within the raphe nuclear complex and serotonergic
circuitry throughout the brain. Recent studies have demonstrated altered raphe-derived
5HT transporter (SERT) immunoreactive axonal expression in several cortical target sites
after brief perinatal exposure to selective 5HT reuptake inhibitors such as citalopram
(CTM). Since the serotonergic raphe nuclear complex projects to the olfactory bulb (OB)
and perinatal 5HT disruption has been shown to disrupt olfactory behaviors, the goal
of this study was to further investigate such developmental effects in the OB of CTM
exposed animals. Male and female rat pups were exposed to CTM from postnatal day
8–21. After animals reach adulthood (>90 days), OB tissue sections were processed
immunohistochemically for SERT antiserum. Our data revealed that the density of the
SERT immunoreactive fibers decreased ∼40% in the OB of CTM exposed male rats, but
not female rats. Our findings support a broad and long-lasting change throughout most of
the 5HT system, including the OB, after early manipulation of 5HT. Because dysfunction of
the early 5HT system has been implicated in the etiology of neurodevelopmental disorders
such as autism spectrum disorders (ASDs), these new findings may offer insight into the
abnormal olfactory perception often noted in patients with ASD.
Keywords: serotonin transporter, olfactory bulb, selective serotonin reuptake inhibitors, sexual dimorphism,
autism spectrum disorders
INTRODUCTION
Serotonin (5HT) is a widely distributed neuromodulator that
plays an important role in regulating brain development (Gaspar
et al., 2003). 5HT neurons in the dorsal raphe nucleus mid-
line group and median raphe nucleus have axons distributed
throughout the brain including the cortex (Waterhouse et al.,
1986) and the olfactory bulb (OB) (McLean and Shipley, 1987).
Manipulation of this system during early stages of neurodevel-
opment has been shown to produce sex-specific neurobehavioral
modifications that persist well into adulthood (Csaba et al., 2003;
Hohmann et al., 2007; Uçeyler et al., 2010). For example, seroton-
ergic neurotoxin injections with 5,7-dihydroxytrypatmine into
the bilateral medial forebrain bundles of neonatal mice induced
long-term changes in social and sensory behaviors, as well as a
depletion of the 5HT-immunoreactive (5HT-ir) fibers in the cere-
bral cortex (Boylan et al., 2007). Similarly, brief neonatal exposure
to the selective serotonin reuptake inhibitor (SSRI) citalopram
(CTM) lead to a sex-specific reduction of SERT-ir fibers in the
neocortex (∼40%) and hippocampus (∼55%) of adult male rats
(Maciag et al., 2006; Weaver et al., 2010). These male rats dis-
played reductions in novel object exploration, reduced social
juvenile play (Rodriguez-Porcel et al., 2011), altered auditory
sensory information processing, and reduced interhemispheric
callosal connections (Simpson et al., 2011). In accordance with
these findings seen in rats exposed neonatally to SSRIs, the inbred
BTBR mice also display abnormalities in social juvenile play
and have decreased (∼20–30%) 5HT transporter (SERT) bind-
ing capacity throughout the brain (Gould et al., 2011). Depletion
of 5HT in the OB affected olfactory recognition in neonate rats
(Dulcy et al., 2010), and caused glomerular atrophy (Moriizumi
et al., 1994). In addition, olfactory sensitivity has been shown
to decrease after 3 weeks of CTM administration in adult mice
(Lombion et al., 2008).
These lines of converging information demonstrate the impor-
tance of 5HT in the proper development of 5HT circuitry, and
when manipulated via environmental and/or genetic means, lead
to abnormal behaviors and altered innervation patterns within
5HT efferents. Therefore, our hypothesis was that brief neona-
tal CTM exposure will have a sex-specific effect on SERT-ir fibers
within the OB, with male abnormalities being more robust.
MATERIALS AND METHODS
All procedures were approved by the University of Mississippi
Medical Center Institutional Animal Care and Use Committee
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and complied with the Association for Assessment and
Accreditation of Laboratory Animal Care International and
National Institutes of Health guidelines.
ANIMALS AND TISSUE PREPARATION
After the delivery of timed-pregnant Long Evans rats, the off-
spring were cross fostered to produce litters of 4∼5 pups. The
pups were tattooed for identification on postnatal day (PN) 6,
weaned at PN28, and housed in groups of 2∼3/cage under stan-
dard laboratory conditions with ad-libitum access to food and
water. Beginning on PN8, the pups were injected subcutaneously
with CTM (10mg/kg, Tocris, Ellisville, MO) or saline in a volume
of 0.1ml twice daily (total CTM dose of 20mg/kg/day or saline
volume of 0.2ml/day) for 14 days (PN8–21). This time window
corresponds roughly from late stages of gestation to first 3 years
of postnatal life in humans (Maciag et al., 2006). In addition, a
non-treatment (NT) group (handled but without injection) was
also included as a control for the effects of injection. The ratio-
nale behind the CTM dose was based on similar blood serum
levels detected in rodents (Kugelberg et al., 2001) and humans
(Bjerkenstedt et al., 1985), and similar dosages have been used and
reported in previous rodent studies (Maciag et al., 2006; Weaver
et al., 2010; Simpson et al., 2011).
After reaching adulthood (PN > 60), animals were deeply
anesthetized with pentobarbital (75mg/kg, i.p.) and perfused
through the ascending aorta with 0.9% saline, followed by 3.5%
paraformaldehyde in 0.1M phosphate buffered saline (PBS). The
brains were extracted and stored in 3.5% paraformaldehyde solu-
tion and 25% sucrose overnight at 4◦C until slicing.
IMMUNOHISTOCHEMISTRY
Rats from each treatment group were randomly divided into sub-
sets and then processed and analyzed in these subsets to minimize
immunostaining variability. For example, three rat brains (one
non-treatment, one saline exposed, and one CTM exposed) were
sliced and processed on the same day. Comparison of the SERT-ir
fibers in rat OB was based initially on three male experimental
subsets and three female experimental subsets. Two additional
female sets were added to ensure no effect of treatment since no
obvious alterations were noted in the female subsets.
In general, we followed the three-step indirect immunohisto-
chemical procedures and quantification methods described pre-
viously (Maciag et al., 2006; Weaver et al., 2010). Specifically,
60μm coronal sections were taken throughout the OB using a
freezing microtome and placed in individual wells. One out of
every six sections were incubated in rabbit anti-SERT antibody
(1:1000, Immunostar, Hudson, WI) for 24 h at room temperature
followed by another 24 h at 4◦C. After rinse, sections were incu-
bated in biotinylated anti-rabbit IgG (1:100, BA1000, ABC kit,
Vector Laboratories, Burlingame, CA) for 1 h at room tempera-
ture. Axon profiles were then visualized by incubating the sections
in Cy3-conjugated streptavidin (1:200, Jackson Immunoresearch
Laboratories, Inc., West Grove, PA) for 1 h at room tempera-
ture in the dark. For each step of staining within a subset, total
volumes of solution were created and distributed equally across
animals to eliminate variability in concentrations within subsets.
Finally, sections were mounted on gelatin-coated slides, allowed
to air dry, and were then covered with DPX (mixture of distyrene,
plasticizer, and xylene).
To control for non-specific labeling, two basic procedures
were utilized. First, we conducted experiments where sections
were processed according to the protocol, except that the pri-
mary SERT antiserum was omitted. Following this procedure,
no SERT immunoreactivity was detected. Another control study
also yielded negative immunostaining when an inappropriate sec-
ondary antibody such as biotinylated anti-mouse IgG (1:100,
BA9200, ABC kit, Vector Laboratories, Burlingame, CA) was used
for linkage.
IMAGE ACQUISITION AND ANALYSIS
Digital photomicrographs of sections containing the area of
the main OB (Paxinos and Watson, 1986, bregma at 6.7mm)
were taken with a consistent exposure time at 20× magnifica-
tion using a Nikon E800 epifluorescent microscope equipped
with a SenSys cool camera (Roper Scientific). The 20× mag-
nification yielded 344 × 437μm terminal field area. For each
animal, three different sub-regions of the OB were chosen: the
glomerular layer, the external plexiform layer, and the granule cell
layer.
A previous study suggested that the glomerular layer in the
dorsal andmedial region of the OB has a higher number of SERT-
ir fibers than those located in the lateral region (Gomez et al.,
2005). Therefore, in order to reduce the sampling bias for the
glomerular layer, we routinely took four images of the SERT-ir
fibers from the middle portion of both medial and lateral regions
of the OB. The same strategies of acquiring pictures were used for
the external plexiform and the granule cell layers.
MetaMorph imaging software (Universal Imaging Systems)
was used as described previously (Maciag et al., 2006; Weaver
et al., 2010) to quantify the density of the SERT-ir fibers in the
OB. Briefly, the signals on the photo were first adjusted to the
same brightness. After thresholding the photo, the background
was excluded and the SERT fibers were selected. A rectangular
region (125 × 100μm for the glomerular layer, 437 × 295μm for
the external plexiform layer, and 437 × 280μm for the granule
cell layer) was created and placed on the photograph to include
the specified layer. The area of this region also served as the ref-
erence point. The percentage of accumulated area of SERT fibers
divided by the area of the rectangular region was defined as the
SERT fiber density within this specific layer. The fiber density
for each layer of an individual animal was determined by aver-
aging the densities obtained from the four images. Data were
analyzed statistically using MANOVAs with post-hoc Tukey’s HSD
tests (SPSS 19, IBM).
RESULTS
DISTRIBUTION AND MORPHOLOGY OF SERT-ir FIBERS
In both male and female control rats, the majority of SERT-ir
fibers appear rather smooth and fine in caliber with very few vari-
cosities (Figure 1A). Most of SERT-ir fibers in the granule cell
layer tended to run parallel to the pia surface, and many of the
SERT-ir fibers in the external plexiform layer were either perpen-
dicular or parallel to the pia surface. In contrast, SERT-ir fibers
in the glomerular layer were mostly randomly distributed. This
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FIGURE 1 | Representative photomicrographs showing the altered
morphology of SERT-ir fibers in the OB of male rats. (A) Normal
SERT-ir fibers exhibit a smooth and fine morphology with very few
varicosities. (B,C) Beaded-like SERT-ir fibers (thin arrows) were noted in
CTM exposed male rats. (C,D) The SERT-ir fibers with large bouton-like
appearance (thick arrows) were noted in CTM exposed male rats. Scale
bar = 2μm. NT, non-treatment; CTM, citalopram; OB, olfactory bulb;
SERT, serotonin transporter.
general pattern of SERT-ir fiber distribution did not change in
CTM exposed animals.
In contrast to the smooth and fine morphology of the SERT-ir
fibers commonly seen in control animals, sex-specific varicosities
were frequently noted in the glomerular layer of CTM exposed
male animals (Figures 1B,C). These varicosities were found less
frequently in the external plexiform and the granule cell lay-
ers. The distance between these varicosities along the SERT-ir
fibers was usually very close and they were mainly in the range
of ∼1–3μm apart. In addition, enlarged bouton-like swellings
(Figures 1C,D) were occasionally noted in the granule cell layer
of CTM exposed male rats. In contrast to these layer-specific mor-
phological changes in male rats neonatally exposed to CTM, such
changes were not seen in the female populations.
DENSITY OF THE SERT-ir FIBERS IN MALE RATS
Representative photos demonstrating the alteration of SERT-ir
fiber density in the OB of male rats were shown in Figure 2. A one
way MANOVA revealed a significant effect of treatment in the
density of SERT-ir fibers within the glomerular layer of male rats,
F(2, 6) = 10.82, p = 0.010, within the external plexiform layer,
F(2, 6) = 6.47, p = 0.032, and within the granule layer, F(2, 6) =
38.81, p < 0.000. Compared to SAL exposed rats, Tukey’s HSD
post-hoc tests revealed that SERT-ir fiber density within the OB
of CTM exposed male rats was significantly reduced ∼39% in
the glomerular layer (p = 0.015),∼38% in the external plexiform
layer (p = 0.034), and ∼38% in the granule cell layer (p = 0.001)
(Figure 3A). Importantly, there were no significant differences in
SERT-ir fiber density between NT and SAL exposed rats within
any of the three OB layers (p ≥ 0.79) (Figure 3A), demonstrating
that the effect was not due to the injections. The data from each
experimental subset of male rats are listed in Table 1.
DENSITY OF THE SERT-ir FIBERS IN FEMALE RATS
Interestingly, SERT-ir fiber density within the OB of female rats
showed a different pattern compared to that discovered in male
rats. Representative photos were shown in Figure 4. Specifically, a
one way MANOVA revealed a non-significant effect of treatment
within the glomerular layer F(2, 12) = 0.173, p = 0.843, within
the external plexiform layer F(2, 12) = 0.300, p = 0.746, and
within the granule layer F(2, 12) = 0.464, p = 0.640 (Figure 3B).
The data from each experimental subset of female rats are listed
in Table 2.
DISCUSSION
We examined the neurodevelopmental effects of neonatal CTM
exposure on the expression of SERT-ir fibers in the OB of adult
rats. Our data revealed that disruption of the 5HT system during
early life lead to a sex-specific and long-lasting change in the mor-
phology and density of the SERT-ir fibers within the OB of adult
male rats. This suggests a sexually dimorphic response to altered
levels of neonatal 5HT, which is consistent with previous rodent
studies (Csaba et al., 2003; Hohmann et al., 2007; Uçeyler et al.,
2010), and further supports this model in the etiology of neurode-
velopmental disorders (Rodriguez-Porcel et al., 2011; Simpson
et al., 2011).
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FIGURE 2 | Representative photomicrographs illustrating the
distribution pattern of SERT-ir fibers in the OB of male rats.
(A1–C1) The glomerular layer. (A2–C2) The external plexiform layer.
(A3–C3) The granule cell layer. Note that SERT-ir fiber density in CTM
(C1–C3) exposed rats was reduced in all three layers compared to NT
(A1–A3) and SAL (B1–B3) exposed male rats. Scale bar = 50μm. NT,
non-treatment; SAL, saline; CTM, citalopram; OB, olfactory bulb; SERT,
serotonin transporter.
TECHNICAL CONSIDERATIONS
It has been well-documented that the 5HT immunostain-
ing patterns within the OB are reliably represented by using
SERT immunostaining, but minor differences between the two
biomarkers have been noted. For example, a greater number of
SERT-ir fibers have been observed in the infraglomerular layer
of the OB compared to 5HT-ir fibers, and the authors suggested
that 5HT immunostaining may not effectively reveal neuronal
processes in cells with a low concentration of intracellular 5HT
(Gomez et al., 2005). Furthermore, the SERT protein was found
within serotonergic axon bundles in addition to axon terminals,
which makes it a useful biomarker for examining serotonergic
axons (Zhou et al., 1998).
The layer-specific density of 5HT-ir fibers in the OB of normal
adult male rats has been reported to be ∼8.8% in the glomerular
layer, ∼3.5% in the granule cell layer, and ∼1.8% in the exter-
nal plexiform layer (McLean and Shipley, 1987). In the current
study, a similar pattern of the SERT-ir fiber density was observed
in control animals with∼13.3% in the glomerular layer,∼8.4% in
the granule cell layer, and ∼2.8% in the external plexiform layer,
supporting the relative reliability of these two immunomarkers.
Appropriate measures were employed to ensure that our anal-
ysis was not biased by our staining and sampling procedures. For
example, image quantification was done independently by two
investigators blind to experimental conditions in order to ver-
ify interrater reliability. In addition, the staining procedures were
processed in sets to minimize staining variability across groups.
In fact, the Levene’s test of equality of error variances was not sig-
nificant within any of the three OB layers of male rats (p ≥ 0.604)
or female rats (p ≥ 0.113), demonstrating equal error variances
across groups.
COMPARISON OF SERT-ir FIBER MORPHOLOGICAL CHANGES WITH
OTHER STUDIES
In the present study, varicosities (∼1–3μm apart) on SERT-ir
fibers were frequently noted in the glomerular layer of CTM
exposed male rats, while these varicosities were less often found
in the external plexiform and the granule cell layers. This is
consistent with previous studies that found more 5HT-ir fibers
with varicosities (∼2–20μm apart) in the glomerular layer
compared to the infraglomerular layer (McLean and Shipley,
1987), and SERT-ir fibers with varicosities within the glomerular
layer (Gomez et al., 2005) of normally developing rodents. The
increased prevalence of dystrophic fibers seen in CTM exposed
animals suggests altered function and may impair serotonergic
signaling throughout the brain.
An increased number of dystrophic thick SERT-ir fibers has
been noted in the amygdala, the hippocampus, and the cortex
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FIGURE 3 | Quantitative analysis of SERT-ir fiber density in the OB of
both male and female rats. (A) The density of the SERT-ir fibers was
significantly decreased in all three layers of the OB in CTM exposed
male rats compared to SAL exposed male rats. (B) However, such
changes were not significantly different in female rats. Error bars =
SEM. ∗Represents p < 0.05 compared to SAL group. NT, non-treatment;
SAL, saline; CTM, citalopram; OB, olfactory bulb; SERT, serotonin
transporter.
Table 1 | SERT-ir fiber density in the olfactory bulb of male rats.
Subset Glomerular layer (%) External plexiform layer (%) Granule cell layer (%)
NT SAL CTM NT SAL CTM NT SAL CTM
1 11.8 13.0 6.6 3.0 2.5 1.9 7.7 8.7 5.4
2 15.3 15.3 8.4 3.1 3.3 2.1 8.5 8.0 5.6
3 12.7 12.1 9.2 2.2 3.2 1.4 8.9 8.5 4.6
Mean 13.3 13.5 8.1 2.8 3.0 1.8 8.4 8.4 5.2
SEM 1.0 0.9 0.8 0.3 0.2 0.2 0.4 0.2 0.3
NT, non-treatment; SAL, saline; CTM, citalopram; SEM, standard error of the mean.
of autistic patients (Azmitia et al., 2011). Interestingly, rodents
exposed neonatally to CTM showed an increased number of thick
and rod-like SERT-ir fibers and/or fine and beaded SERT-ir fibers
in the cortex and hippocampus (Maciag et al., 2006; Weaver et al.,
2010). However, in the present study, very few SERT-ir fibers in
the OB showed this pattern after neonatal exposure to CTM. One
possible explanation for this discrepancy could be that the neu-
rochemical composition of the OB raphe projecting system may
be different from cortical raphe projecting system. For example,
the majority of cortical projecting 5HT neurons are in the midline
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FIGURE 4 | Representative photomicrographs illustrating the
distribution pattern of SERT-ir fibers in the OB of female rats.
(A1–C1) The glomerular layer. (A2–C2) The external plexiform layer.
(A3–C3) The granule cell layer. Note that SERT-ir fiber density remained
unchanged in all three layers of NT (A1–A3), SAL (B1–B3), and CTM
(C1–C3) exposed female rats. Scale bar = 50μm. NT, non-treatment;
SAL, saline; CTM, citalopram; OB, olfactory bulb; SERT, serotonin
transporter.
Table 2 | SERT-ir fiber density in the olfactory bulb of female rats.
Subset Glomerular layer (%) External plexiform layer (%) Granule cell layer (%)
NT SAL CTM NT SAL CTM NT SAL CTM
1 11.9 11.8 13.6 1.9 2.6 2.6 8.8 5.3 10.4
2 12.2 12.1 11.1 2.0 2.2 1.6 8.1 7.5 7.3
3 12.1 10.0 11.2 2.2 1.8 1.6 6.1 7.3 6.2
4 11.4 13.2 11.6 2.3 2.2 2.4 9.3 8.6 6.5
5 13.8 12.3 13.2 2.5 1.7 1.8 6.3 4.6 3.1
Mean 12.3 11.9 12.1 2.2 2.1 2.0 7.7 6.7 6.7
SEM 0.4 0.5 0.5 0.1 0.2 0.2 0.7 0.7 1.2
NT, non-treatment; SAL, saline; CTM, citalopram; SEM, standard error of the mean.
subgroup of the raphe complex co-express nitric oxide and 5HT
(Simpson et al., 2003; Lu et al., 2010), and it is currently unknown
whether this is the case for the OB projecting raphe neurons.
SEXUAL DIMORPHISM OF THE 5HT SYSTEM
At present, a limited number of studies have examined sexual dif-
ferences within the developing 5HT system of human or rodent
brains. It was reported that cortical 5HT content in normal male
mice was twice that of female mice at PN3 (Connell et al., 2004).
In healthy young humans, 5HT synthesis capacity was higher in
boys compared to girls (Chugani et al., 1999), and similarly higher
in healthy adult men compared to women (Sakai et al., 2006).
In contrast, 5HT levels were reported to be higher in the brain-
stem and limbic forebrain of female rats compared to male rats
(Carlsson and Carlsson, 1988).
The major support for the sexually dimorphic development of
the 5HT system is from rodent studies that have demonstrated
sex-specific effects after early life manipulation of brain
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5HT levels. For example, it was reported that 5HT depleted male
animals showed reduced exploration in response to spatial rear-
rangement and object novelty, however, this effect was not found
in females (Hohmann et al., 2007). Similarly, physical activity
was reduced in adult male SERT knock-out mice compared to
females (Uçeyler et al., 2010). Furthermore, after a single injec-
tion of 5HT into newborn rats, 5HT levels were reduced in the
striatum of adult male rats and displayed increased sexual activ-
ity, while no obvious differences were detected in adult female
rats (Csaba et al., 2003). Interestingly, perinatal exposure to CTM
affected male locus coeruleus circuit function but was not seen
in females (Darling et al., 2011). Because a variety of early-life
5HT-system manipulations produce a constellation of long-term
and sex-specific effects, it is not surprising that we observed a sex-
specific reduction of SERT-ir fiber density in the OB of only male
rats after neonatal CTM exposure.
Taken together, the current investigation and previous studies
suggest that a sexual dimorphism does exist in both the nor-
mally developing 5HT system and after manipulations of brain
5HT levels. At present, the precise biological mechanism(s) of
such sexual differences during early development are not known.
Nonetheless, the neurodevelopmental consequences of these sex-
ual differences need to be explored as it pertains to neurodevelop-
mental and psychiatric disorders that exhibit sex specificity.
FUNCTIONAL SIGNIFICANCE AND CLINICAL IMPLICATIONS
Recently, our laboratory and others have suggested that manip-
ulation of perinatal 5HT levels induce numerous neurological
and behavioral abnormalities, similar to what have been observed
in autistic patients. For example, patients with autism spectrum
disorder (ASDs) have been known to show impaired social inter-
actions (Wing and Gould, 1979), a disrupted 5HT system in the
brain (Chugani et al., 1999; Makkonen et al., 2008; Nakamura
et al., 2010), as well as under-connectivity between two corti-
cal hemispheres (Just et al., 2004; Vidal et al., 2006; Courchesne
et al., 2007; Damarla et al., 2010). In addition, a recent study
reported that exposure to SSRIs during pregnancy increased the
risk of ASD diagnosis by a factor of more than two (Croen
et al., 2011). These new lines of evidence suggest that dysregu-
lation of 5HT levels may be one of the contributing factors for
ASDs.
In addition to the core symptoms commonly seen in ASD,
autistic patients are also known to display high incidence of sen-
sory abnormalities (Rogers and Ozonoff, 2005). For example, it
was reported that over 90% of children with ASDs had multiple
sensory abnormalities (Leekam et al., 2007). Abnormal responses
to multisensory information such as touch, oral, and olfactory
stimuli have been proposed as predictors of the social sever-
ity in children with ASDs (Hilton et al., 2010). Other studies
reported either disrupted olfactory identification (Suzuki et al.,
2003; Bennetto et al., 2007; May et al., 2011) or altered odor sensi-
tivity (Tomchek and Dunn, 2007; Dudova et al., 2011) in patients
with ASDs. At present, the neurochemical and neuroanatomi-
cal foundations of the altered olfactory information processing
in patients with ASDs remain unclear, but this model of early-
life 5HT manipulation may help elucidate the cause of these
widespread sensory abnormalities.
Lastly, 5HT has been shown to play an important role in the
rodent olfactory system, and disruption of 5HT levels lead to
abnormal olfactory odor transmission. For example, 5HT was
reported to be necessary in conditioned olfactory learning in
rats (McLean et al., 1993; Moriizumi et al., 1994; Dulcy et al.,
2010), mediated through 5HT2A/2C receptors (McLean et al.,
1996; Hardy et al., 2005). These previous findings along with
our present data suggest a potential link between an altered 5HT
system in the OB and the abnormal olfactory function noted
in rats and patients with ASDs. However, it may be premature
to suggest that an altered serotonergic system in the OB offers
a possible clinical explanation for abnormal odor information
process frequently noted in patients with ASDs. Therefore, addi-
tional behavioral tests of olfactory function in our animal model
warrant further investigation.
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